ArticleEuropean journal of clinical pharmacology2025
Influence of ultrafiltration conditions on the unbound fraction of phenytoin and valproic acid.
Article in European journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study was designed to analyse the influence of temperature, pH and storage time on unbound fractions of PHT and VPA.
methodsThe influence of ultrafiltration (UF) temperature on measured unbound fractions of PHT and VPA in spiked samples was evaluated in a single laboratory experiment and in data from a national external quality control (EQC) database. The influence of pH adjustment with phosphate buffered saline (PBS) on measured unbound fractions of PHT and VPA was investigated in patient samples. The influence of storage time on unbound fractions of PHT and VPA was examined in patient samples by performing UF at various time points.
resultsPerforming UF at a temperature of 37 °C compared to 20 °C significantly increased (p < 0.05) the measured unbound fractions for both PHT (range 14.8-26.3%) and VPA (range 5.7-16.0%) in the single laboratory experiment. Consistent with these findings, reported unbound fractions in the ECQ database of PHT were significantly higher with UF at 37 °C compared to room temperature. For VPA, this was not the case. However, for both drugs, the number of laboratories performing UF at 37 °C was limited (n = 2-4). Adjustment of pH with PBS was unfeasible. After 4 days of storage at 5 °C, the unbound fraction of PHT seemed to remain stable whereas the unbound fraction of VPA appeared to increase (27.4%) (n = 3).
conclusionHigher UF temperatures led to an increase in measured unbound fractions of both PHT and to a lesser extent VPA. Storage time of plasma samples might influence the unbound fraction of VPA.
Indexed as
Identifiers
40924145What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.